Piedmont Lithium Reports Q1 2025 Results
-
Piedmont recorded Q1’25 shipments of approximately 27,000 dmt of spodumene concentrate at an average realized price of per dmt and revenue of$741 $20.0 million -
NAL produced 43,621 dmt in Q1’25,
80% mill utilization, and69% lithium recovery -
Piedmont had in cash and cash equivalents as of March 31, 2025$65.4 million - Merger with Sayona Mining to form Elevra Lithium advancing with an expected closing in mid-2025
NAL produced 43,621 dmt of spodumene concentrate during the quarter. Lithium recovery improved to
Our joint venture Ewoyaa Lithium Project (“Ewoyaa”) in
The Company continued to execute against its plan to delay capital expenditures into 2025 and beyond. As it relates to the Carolina Lithium Project, the Company evaluated its strategic land position within the Carolina Tin-Spodumene Belt and adjusted scheduled land purchases to minimize near-term capital expenditures. In addition,
“Our first quarter results reflect continued operational progress and the resilience of our team” said Keith Phillips, President and CEO of Piedmont Lithium. “We achieved record lithium recoveries at North American Lithium and the operation remains on track to meet shipment and cost guidance, despite weather-related impacts to mill utilization. In addition, we continued to take a disciplined approach to capital spending while making strong progress toward our planned merger with Sayona. We believe the proposed combination will enhance value for shareholders and position Elevra Lithium as a leading supplier to the North American battery supply chain,” added Phillips.
1 The timing of shipments is subject to shipping logistics, port and weather conditions, and customer requirements. |
2 See Sayona Mining Quarterly Activities Report filed with the ASX on April 29, 2025. |
Proposed Merger of Piedmont Lithium and Sayona Mining
Piedmont Lithium and Sayona signed a definitive merger agreement on November 19, 2024 to combine the two companies (the “Merger”) to create a leading North American lithium business.
The Merger is expected to close in mid-2025, subject to stockholder approval for both companies. A proxy statement containing important information about the Merger will be sent to
Since the announcement, significant progress has been made in preparing for shareholder votes for
- Subject to Sayona shareholder approval, the combined company will be renamed Elevra Lithium Limited (“Elevra”) and will trade under the ticker symbol “ELV” on the ASX and ticker symbol for the American Depositary Shares (“ADS”) traded on the Nasdaq will be “ELVR”;
-
The nominees for the Board of Elevra, which will be constituted of 4 members from the existing
Piedmont Board and 4 members of the existing Sayona Board; -
Regulatory approval for the Investment Canada Act and the Hart-Scott-Rodino Act, and completion of review by the Committee on Foreign Investment in
the United States ; - Subject to Sayona shareholder approval, a reverse stock split to consolidate Sayona’s shares at a ratio of 1-for-150 prior to the completion of the Merger, which will update the exchange ratio to 3.5133 Sayona shares for each Piedmont Lithium share compared to the previously announced 527 Sayona shares for each Piedmont Lithium share; and
- Each Sayona ADS issued in the Merger will represent 1,500 Sayona shares prior to the effect of the reverse stock split or 10 Sayona shares after the reverse stock split.
First Quarter 2025 Financial Highlights
All references to dmt in this release relate to spodumene concentrate.
|
|
Units |
|
Q1’25 |
|
Q4’24 |
|
Q1’24 |
|||
Sales |
|
|
|
|
|
|
|
|
|
|
|
|
Concentrate shipped |
dmt thousands |
|
27.0 |
|
|
55.7 |
|
|
15.5 |
|
|
Revenue |
$ millions |
|
20.0 |
|
|
45.6 |
|
|
13.4 |
|
|
Realized price(1) |
$/dmt |
|
741 |
|
|
818 |
|
|
865 |
|
|
Li2O content(2) |
% |
|
5.4 |
|
|
5.4 |
|
|
5.5 |
|
|
Realized cost of sales(3) |
$/dmt |
|
736 |
|
|
696 |
|
|
799 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Profitability |
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
$ millions |
|
0.1 |
|
|
6.8 |
|
|
0.7 |
|
|
Gross profit margin |
% |
|
0.7 |
|
|
15.0 |
|
|
5.2 |
|
|
Net loss |
$ millions |
|
(15.6) |
|
|
(11.1) |
|
|
(23.6) |
|
|
Diluted EPS |
$ |
|
(0.71) |
|
|
(0.55) |
|
|
(1.22) |
|
|
Adjusted net loss(4) |
$ millions |
|
(10.1) |
|
|
(3.6) |
|
|
(11.9) |
|
|
Adjusted diluted EPS(4) |
$ |
|
(0.46) |
|
|
(0.17) |
|
|
(0.61) |
|
|
Adjusted EBITDA(4) |
$ millions |
|
(10.1) |
|
|
(3.7) |
|
|
(12.4) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash |
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents(5) |
$ millions |
|
65.4 |
|
|
87.8 |
|
|
71.4 |
|
___________________________________________________________ | ||
(1) |
Realized price is the average estimated price, net of certain distribution and other fees, which includes reference pricing data up to the respective period end and is subject to final adjustment. The final adjusted price may be higher or lower than the estimated average realized price based on future price movements. |
|
(2) |
Weighted average Li2O content for shipments made during the respective period. |
|
(3) |
Realized cost of sales is the average cost of sales including Piedmont’s offtake pricing agreement with Sayona Quebec Inc. (“Sayona Quebec”) for the purchase of spodumene concentrate at a market price subject to a floor of |
|
(4) |
See non-GAAP Financial Measures at the end of this release for a reconciliation of non-GAAP measures. |
|
(5) |
Cash and cash equivalents are reported as of the end of the period. |
First Quarter and Recent Business Highlights
Piedmont Lithium
-
Shipped approximately 27,000 dmt (~
5.4% Li2O) of spodumene concentrate from NAL to customers in Q1’25 and recognized in revenue with an average realized sales price of$20.0 million per dmt. On an SC6 equivalent basis, our realized price per metric ton was$741 .$823 -
Piedmont continued to advance the proposed merger with Sayona and reached several milestones in preparation for the shareholder vote. In April, the companies jointly announced the combined company would be renamed Elevra and disclosed the slate of nominees for the Board of Directors which includes 4 members of Piedmont’s existing Board, including Dawne Hickton who has been nominated as the Chair Designate of Elevra. -
In April 2025,
Piedmont announced key regulatory approvals for the merger were received inthe United States andCanada . -
In April 2025,
Piedmont announced the signing of a revised merger agreement with Sayona which incorporated, among other things, an updated exchange ratio to incorporate the terms of a proposed reverse stock split to be undertaken by Sayona as part of the merger, subject to Sayona shareholder approval.
North American Lithium (
-
In Q1’25, NAL achieved quarterly production of 43,261 dmt and shipped approximately 27,000 dmt, all of which were sold to
Piedmont . -
Production declined by approximately
15% compared to the prior quarter. The decline was primarily related to a reduction in mill utilization for the quarter, which was80% , due to a combination of weather-related unplanned downtime and a scheduled maintenance shutdown. Lithium recovery improved modestly to69% during the quarter and set a new monthly record of72% in March. - In April, the final results from the 2024 NAL drilling program were released. The results reinforce the potential for a future expansion at NAL and will be incorporated into an updated Mineral Resource Estimate, which is expected to be released in the middle of 2025.
-
Concentrate shipped by
Piedmont and produced and shipped by NAL:
|
|
Share |
|
Units |
|
Q1’25 |
|
Q4’24 |
|
Q1’24 |
Piedmont Lithium |
|
|
|
|
|
|
|
|
|
|
|
Concentrate shipped |
|
|
dmt thousands |
|
27.0 |
|
55.7 |
|
15.5 |
|
|
|
|
|
|
|
|
|
|
|
North American Lithium |
|
|
|
|
|
|
|
|
|
|
|
Concentrate produced |
|
|
dmt thousands |
|
43.3 |
|
50.9 |
|
40.4 |
|
Concentrate shipped |
|
|
dmt thousands |
|
27.0 |
|
66.0 |
|
58.0 |
___________________________________________________________ |
(1) Concentrate produced represents |
(2) Concentrate shipped represents |
Note: The table above reports quarterly and year-to-date information in accordance with Piedmont’s fiscal year reporting, which is on a calendar-year basis. Concentrate produced and concentrate shipped (above) are reported in the periods in which activities occurred. For financial statement purposes, |
Ewoyaa Lithium Project (
- In January 2025, the Ewoyaa project was granted a Water Use Permit by the Ghanaian Water Resources Commission and Atlantic Lithium announced a JORC compliant Mineral Resource Estimate of feldspar, which is intended to supply the Ghanaian ceramics market.
Carolina Lithium (
-
Piedmont continues to pursue an air permit application currently under review by North Carolina’s Division of Air Quality, which would allow for up to 60,000 tons per year of lithium hydroxide production at Carolina Lithium, and a North Carolina General Stormwater permit.
2025 Outlook
|
Units |
|
Q1’25 |
|
Q2’25 |
|
FY25 |
Shipments |
dmt thousands |
|
27 |
|
8 — 20 |
|
113 — 130 |
Capital expenditures |
$ millions |
|
1 |
|
1 — 2 |
|
4 — 6 |
Investments in and advances to affiliates |
$ millions |
|
1 |
|
2 — 4 |
|
7 — 13 |
Under our offtake agreement with Sayona Quebec,
We expect less than
Safety and Sustainability
The Company continued policy development and training to support the long-term objective of establishing a robust safety and health management system. Employee engagement in safety events remained strong and identification and reporting of hazards, unsafe acts, conditions, and safety observations, and near misses continued to improve.
Piedmont Lithium Earnings Call Information
Date: |
|
Wednesday, May 7, 2025 |
Time: |
|
4:30 p.m. Eastern Standard Time |
Dial-in (Toll Free): |
|
1 (800) 715-9871 |
Dial-in (Toll): |
|
1 (646) 307-1963 |
Conference ID: |
|
9176321 |
Participant URL: |
|
Piedmont’s earnings presentation and supporting material are available at:
https://piedmontlithium.com/investors-overview.
About
Piedmont Lithium Inc. (Nasdaq: PLL; ASX: PLL) is developing a world-class, multi-asset, integrated lithium business focused on enabling the transition to a net zero world and the creation of a clean energy economy in
Cautionary Note to U.S. Investors
Piedmont’s public disclosures are governed by the
The statements in the link below were prepared by, and made by, NAL. The following disclosures are not statements of
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of or as described in securities legislation in
PIEDMONT LITHIUM INC. CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except per share amounts) (Unaudited) |
||||||||
|
|
Three Months Ended March 31, |
||||||
|
|
|
2025 |
|
|
|
2024 |
|
Revenue |
|
$ |
19,996 |
|
|
$ |
13,401 |
|
Costs of sales |
|
|
19,862 |
|
|
|
12,710 |
|
Gross profit |
|
|
134 |
|
|
|
691 |
|
Exploration costs |
|
|
— |
|
|
|
53 |
|
Selling, general and administrative expenses |
|
|
6,771 |
|
|
|
8,094 |
|
Total operating expenses |
|
|
6,771 |
|
|
|
8,147 |
|
Loss from equity method investments |
|
|
(4,935 |
) |
|
|
(5,440 |
) |
Restructuring charges |
|
|
(283 |
) |
|
|
(1,780 |
) |
Loss from operations |
|
|
(11,855 |
) |
|
|
(14,676 |
) |
Interest income |
|
|
699 |
|
|
|
827 |
|
Interest expense |
|
|
(560 |
) |
|
|
(222 |
) |
Loss on sale of equity method investments |
|
|
— |
|
|
|
(13,886 |
) |
Other (loss) income |
|
|
(3,915 |
) |
|
|
1,253 |
|
Total other expense |
|
|
(3,776 |
) |
|
|
(12,028 |
) |
Loss before income taxes |
|
|
(15,631 |
) |
|
|
(26,704 |
) |
Income tax benefit |
|
|
— |
|
|
|
(3,093 |
) |
Net loss |
|
$ |
(15,631 |
) |
|
$ |
(23,611 |
) |
|
|
|
|
|
||||
Basic and diluted: |
|
|
|
|
||||
Net loss per share |
|
$ |
(0.71 |
) |
|
$ |
(1.22 |
) |
Weighted-average shares outstanding |
|
|
21,939 |
|
|
|
19,326 |
|
PIEDMONT LITHIUM INC. CONSOLIDATED BALANCE SHEETS (In thousands, except per share amounts) (Unaudited) |
|||||||
|
March 31, 2025 |
|
December 31, 2024 |
||||
Assets |
|
|
|
||||
Cash and cash equivalents |
$ |
65,390 |
|
|
$ |
87,840 |
|
Accounts receivable |
|
11,861 |
|
|
|
5,613 |
|
Other current assets |
|
5,229 |
|
|
|
9,186 |
|
Total current assets |
|
82,480 |
|
|
|
102,639 |
|
Property, plant and mine development, net |
|
135,649 |
|
|
|
134,544 |
|
Advances to affiliates |
|
40,498 |
|
|
|
39,548 |
|
Other non-current assets |
|
1,454 |
|
|
|
1,519 |
|
Equity method investments |
|
66,908 |
|
|
|
71,635 |
|
Total assets |
$ |
326,989 |
|
|
$ |
349,885 |
|
|
|
|
|
||||
Liabilities and Stockholders’ Equity |
|
|
|
||||
Accounts payable |
$ |
1,411 |
|
|
$ |
5,239 |
|
Accrued expenses |
|
1,878 |
|
|
|
4,313 |
|
Payables to affiliates |
|
5,240 |
|
|
|
6,719 |
|
Current debt obligations |
|
26,237 |
|
|
|
26,472 |
|
Other current liabilities |
|
3,661 |
|
|
|
3,363 |
|
Total current liabilities |
|
38,427 |
|
|
|
46,106 |
|
Long-term debt, net of current portion |
|
3,418 |
|
|
|
3,652 |
|
Operating lease liabilities, net of current portion |
|
817 |
|
|
|
863 |
|
Other non-current liabilities |
|
1,036 |
|
|
|
1,017 |
|
Total liabilities |
|
43,698 |
|
|
|
51,638 |
|
|
|
|
|
||||
Stockholders’ equity: |
|
|
|
||||
Common stock; |
|
2 |
|
|
|
2 |
|
Additional paid-in capital |
|
498,345 |
|
|
|
497,878 |
|
Accumulated deficit |
|
(207,236 |
) |
|
|
(191,605 |
) |
Accumulated other comprehensive loss |
|
(7,820 |
) |
|
|
(8,028 |
) |
Total stockholders’ equity |
|
283,291 |
|
|
|
298,247 |
|
Total liabilities and stockholders’ equity |
$ |
326,989 |
|
|
$ |
349,885 |
|
PIEDMONT LITHIUM INC. CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands) (Unaudited) |
|||||||
|
Three Months Ended March 31, |
||||||
Cash flows from operating activities: |
|
2025 |
|
|
|
2024 |
|
Net loss |
$ |
(15,631 |
) |
|
$ |
(23,611 |
) |
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
||||
Stock-based compensation expense |
|
982 |
|
|
|
2,067 |
|
Loss from equity method investments |
|
4,935 |
|
|
|
5,440 |
|
Loss on sale of equity method investments |
|
— |
|
|
|
13,886 |
|
Loss (gain) on equity securities |
|
3,640 |
|
|
|
(1,384 |
) |
Deferred taxes |
|
— |
|
|
|
(6,246 |
) |
Depreciation and amortization |
|
63 |
|
|
|
81 |
|
Noncash lease expense |
|
42 |
|
|
|
401 |
|
Loss on sale of assets |
|
80 |
|
|
|
— |
|
Unrealized foreign currency translation (gains) losses |
|
(24 |
) |
|
|
128 |
|
Changes in assets and liabilities: |
|
|
|
||||
Accounts receivable |
|
(6,248 |
) |
|
|
(3,652 |
) |
Other assets |
|
350 |
|
|
|
887 |
|
Operating lease liabilities |
|
(40 |
) |
|
|
(396 |
) |
Accounts payable |
|
(3,708 |
) |
|
|
54 |
|
Payables to affiliates |
|
(1,479 |
) |
|
|
1,587 |
|
Other liabilities and accrued expenses |
|
(2,117 |
) |
|
|
(17,564 |
) |
Net cash used in operating activities |
|
(19,155 |
) |
|
|
(28,322 |
) |
Cash flows from investing activities: |
|
|
|
||||
Capital expenditures |
|
(1,366 |
) |
|
|
(5,428 |
) |
Advances to affiliates |
|
(945 |
) |
|
|
(4,977 |
) |
Proceeds from sale of marketable securities |
|
— |
|
|
|
45 |
|
Proceeds from sale of shares in equity method investments |
|
— |
|
|
|
49,103 |
|
Additions to equity method investments |
|
— |
|
|
|
(10,048 |
) |
Net cash (used in) provided by investing activities |
|
(2,311 |
) |
|
|
28,695 |
|
Cash flows from financing activities: |
|
|
|
||||
Proceeds from Credit Facility |
|
10,767 |
|
|
|
— |
|
Settlements of Credit Facility |
|
(10,777 |
) |
|
|
— |
|
Payments of debt obligations and insurance premiums financed |
|
(459 |
) |
|
|
(68 |
) |
Payments to tax authorities for employee stock-based compensation |
|
(515 |
) |
|
|
(591 |
) |
Net cash used in financing activities |
|
(984 |
) |
|
|
(659 |
) |
Net decrease in cash |
|
(22,450 |
) |
|
|
(286 |
) |
Cash and cash equivalents at beginning of period |
|
87,840 |
|
|
|
71,730 |
|
Cash and cash equivalents at end of period |
$ |
65,390 |
|
|
$ |
71,444 |
|
Non-GAAP Financial Measures
The following information provides definitions and reconciliations of certain non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with GAAP. The non-GAAP financial measures presented do not have any standard meaning prescribed by GAAP and may differ from similarly-titled measures used by other companies. We believe that these adjusted measures provide meaningful information to assist management, investors, and analysts in understanding our financial condition and the results of operations. We believe these adjusted financial measures are important indicators of our recurring operations because they exclude items that may not be indicative of, or are unrelated to, our core operating results, and provide a better baseline for analyzing trends in our underlying businesses.
The following are non-GAAP financial measures for
Adjusted net (loss) income is defined as net (loss) income, as calculated under GAAP, plus or minus the gain or loss from sale of equity method investments, gain or loss on sale of assets, gain or loss from equity securities, gain or loss from foreign currency exchange, restructuring charges including severance and severance related costs and exit costs, and certain other adjustments we believe are not reflective of our ongoing operations and performance. These items include acquisition costs and other fees, and shelf registration costs.
Adjusted diluted earnings per share (or adjusted diluted EPS) is defined as diluted EPS, as calculated under GAAP, before gain or loss on sale of equity method investments, gain or loss on sale of assets, gain or loss from equity securities, gain or loss from foreign currency exchange, restructuring charges including severance and severance related costs and exit costs, and certain other costs we believe are not reflective of our ongoing operations and performance.
EBITDA is defined as net income (loss) before interest expenses, income tax expense, and depreciation.
Adjusted EBITDA is defined as EBITDA plus or minus the gain or loss on sale of equity method investments, gain or loss on sale of assets, gain or loss from equity securities, gain or loss from foreign currency exchange, restructuring charges including severance and severance related costs and exit costs, and certain other adjustments we believe are not reflective of our ongoing operations and performance.
Below are reconciliations of non-GAAP financial measures on a consolidated basis for adjusted net (loss) income, adjusted diluted EPS, EBITDA, and adjusted EBITDA.
Adjusted Net Loss and Adjusted Diluted EPS
|
|
Three Months Ended |
||||||||||||||||||||||
|
|
March 31, 2025 |
|
December 31, 2024 |
|
March 31, 2024 |
||||||||||||||||||
(in thousands, except per share amounts) |
|
|
|
Diluted EPS |
|
|
|
Diluted EPS |
|
|
|
Diluted EPS |
||||||||||||
Net loss |
|
$ |
(15,631 |
) |
|
$ |
(0.71 |
) |
|
$ |
(11,131 |
) |
|
$ |
(0.55 |
) |
|
$ |
(23,611 |
) |
|
$ |
(1.22 |
) |
Loss on sale of equity method investments(1) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
13,886 |
|
|
|
0.72 |
|
Loss on sale of assets |
|
|
80 |
|
|
|
— |
|
|
|
100 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Loss (gain) on equity securities(2) |
|
|
3,640 |
|
|
|
0.17 |
|
|
|
(1,791 |
) |
|
|
(0.09 |
) |
|
|
(1,384 |
) |
|
|
(0.07 |
) |
Loss from foreign currency exchange(3) |
|
|
195 |
|
|
|
0.01 |
|
|
|
596 |
|
|
|
0.03 |
|
|
|
131 |
|
|
|
0.01 |
|
Restructuring charges(4) |
|
|
283 |
|
|
|
0.01 |
|
|
|
3,194 |
|
|
|
0.16 |
|
|
|
1,780 |
|
|
|
0.09 |
|
Other costs(5) |
|
|
1,369 |
|
|
|
0.06 |
|
|
|
5,518 |
|
|
|
0.27 |
|
|
|
431 |
|
|
|
0.02 |
|
Tax effect of adjustments(6) |
|
|
— |
|
|
|
— |
|
|
|
(37 |
) |
|
|
— |
|
|
|
(3,093 |
) |
|
|
(0.16 |
) |
Adjusted net loss |
|
$ |
(10,064 |
) |
|
$ |
(0.46 |
) |
|
$ |
(3,551 |
) |
|
$ |
(0.17 |
) |
|
$ |
(11,860 |
) |
|
$ |
(0.61 |
) |
______________________________________________________ | ||
(1) |
Loss on sale of equity method investments includes a loss on the sale of shares in Sayona Mining of |
|
(2) |
Loss (gain) on equity securities represents realized and unrealized gains on our equity security holdings in Atlantic Lithium and Ricca Resources. |
|
(3) |
Loss from foreign currency exchange primarily relates to currency fluctuations in our foreign bank accounts denominated in Canadian dollars and Australian dollars and marketable securities denominated in Australian dollars. |
|
(4) |
Restructuring charges relates to severance and reorganization related costs and exit costs related to our 2024 Cost Savings Plan. |
|
(5) |
Other costs include legal and transactional costs related to certain strategic transactions and shelf registration costs. |
|
(6) |
No income tax impacts have been given to any items that were recorded in jurisdictions with full valuation allowances. |
EBITDA and Adjusted EBITDA
|
Three Months Ended |
||||||||||
(in thousands) |
March 31, 2025 |
|
December 31, 2024 |
|
March 31, 2024 |
||||||
Net loss |
$ |
(15,631 |
) |
|
$ |
(11,131 |
) |
|
$ |
(23,611 |
) |
Interest income, net |
|
(139 |
) |
|
|
(189 |
) |
|
|
(605 |
) |
Income tax benefit |
|
— |
|
|
|
(37 |
) |
|
|
(3,093 |
) |
Depreciation and amortization |
|
63 |
|
|
|
63 |
|
|
|
81 |
|
EBITDA |
|
(15,707 |
) |
|
|
(11,294 |
) |
|
|
(27,228 |
) |
Loss on sale of equity method investments(1) |
|
— |
|
|
|
— |
|
|
|
13,886 |
|
Loss on sale of assets |
|
80 |
|
|
|
100 |
|
|
|
— |
|
Loss (gain) on equity securities(2) |
|
3,640 |
|
|
|
(1,791 |
) |
|
|
(1,384 |
) |
Loss from foreign currency exchange(3) |
|
195 |
|
|
|
596 |
|
|
|
131 |
|
Restructuring charges(4) |
|
283 |
|
|
|
3,194 |
|
|
|
1,780 |
|
Other costs(5) |
|
1,369 |
|
|
|
5,518 |
|
|
|
431 |
|
Adjusted EBITDA |
$ |
(10,140 |
) |
|
$ |
(3,677 |
) |
|
$ |
(12,384 |
) |
______________________________________________________ | ||
(1) |
Loss on sale of equity method investments includes a loss on the sale of shares in Sayona Mining of |
|
(2) |
Loss (gain) on equity securities represents realized and unrealized gains on our equity security holdings in Atlantic Lithium and Ricca Resources. |
|
(3) |
Loss from foreign currency exchange primarily relates to currency fluctuations in our foreign bank accounts denominated in Canadian dollars and Australian dollars and marketable securities denominated in Australian dollars. |
|
(4) |
Restructuring charges relates to severance and reorganization related costs and exit costs related to our 2024 Cost Savings Plan. |
|
(5) |
Other costs include legal and transactional costs related to certain strategic transactions and shelf registration costs. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20250507619139/en/
For further information, contact:
Michael White
Chief Financial Officer
T: +1 713 878 9049
E: mwhite@piedmontlithium.com
John Koslow
Investor Relations
T: +1 908 701 9928
E: jkoslow@piedmontlithium.com
Source: Piedmont Lithium Inc.